Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 18 February 2000:
Vol. 287. no. 5456, pp. 1265 - 1269
DOI: 10.1126/science.287.5456.1265
Prev | Table of Contents | Next

Reports

Dopaminergic Loss and Inclusion Body Formation in alpha -Synuclein Mice: Implications for Neurodegenerative Disorders

Eliezer Masliah, 12* Edward Rockenstein, 1 Isaac Veinbergs, 2 Margaret Mallory, 1 Makoto Hashimoto, 1 Ayako Takeda, 13 Yutaka Sagara, 2 Abbyann Sisk, 2 Lennart Mucke 4

To elucidate the role of the synaptic protein alpha -synuclein in neurodegenerative disorders, transgenic mice expressing wild-type human alpha -synuclein were generated. Neuronal expression of human alpha -synuclein resulted in progressive accumulation of alpha -synuclein--and ubiquitin-immunoreactive inclusions in neurons in the neocortex, hippocampus, and substantia nigra. Ultrastructural analysis revealed both electron-dense intranuclear deposits and cytoplasmic inclusions. These alterations were associated with loss of dopaminergic terminals in the basal ganglia and with motor impairments. These results suggest that accumulation of wild-type alpha -synuclein may play a causal role in Parkinson's disease and related conditions.

1 Department of Neurosciences,
2 Department of Pathology, University of California San Diego, La Jolla, CA 92093-0624, USA.
3 Department of Psychiatry, Yokohama City University, School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236, Japan.
4 Gladstone Institute of Neurological Disease and Department of Neurology, University of California San Francisco, Post Office Box 419100, San Francisco, CA 94141-9100, USA.
*   To whom correspondence should be addressed. E-mail: emasliah{at}ucsd.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in {alpha}-Synuclein Models of Parkinson's and Lewy Body Diseases.
B. Spencer, R. Potkar, M. Trejo, E. Rockenstein, C. Patrick, R. Gindi, A. Adame, T. Wyss-Coray, and E. Masliah (2009)
J. Neurosci. 29, 13578-13588
   Abstract »    Full Text »    PDF »
Prions: Protein Aggregation and Infectious Diseases.
A. Aguzzi and A. M. Calella (2009)
Physiol Rev 89, 1105-1152
   Abstract »    Full Text »    PDF »
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human {alpha}-synuclein in transgenic mouse brain.
K. D. Cronin, D. Ge, P. Manninger, C. Linnertz, A. Rossoshek, B. M. Orrison, D. J. Bernard, O. M.A. El-Agnaf, M. G. Schlossmacher, R. L. Nussbaum, et al. (2009)
Hum. Mol. Genet. 18, 3274-3285
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein contributes to GSK-3{beta}-catalyzed Tau phosphorylation in Parkinson's disease models.
T. Duka, V. Duka, J. N. Joyce, and A. Sidhu (2009)
FASEB J 23, 2820-2830
   Abstract »    Full Text »    PDF »
Repression of {alpha}-synuclein expression and toxicity by microRNA-7.
E. Junn, K.-W. Lee, B. S. Jeong, T. W. Chan, J.-Y. Im, and M. M. Mouradian (2009)
PNAS 106, 13052-13057
   Abstract »    Full Text »    PDF »
Unique copper-induced oligomers mediate alpha-synuclein toxicity.
J. A. Wright, X. Wang, and D. R. Brown (2009)
FASEB J 23, 2384-2393
   Abstract »    Full Text »    PDF »
Deletion of the {alpha}7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease.
G. Dziewczapolski, C. M. Glogowski, E. Masliah, and S. F. Heinemann (2009)
J. Neurosci. 29, 8805-8815
   Abstract »    Full Text »    PDF »
Mice Expressing Mutant Parkin Exhibit Hallmark Features of Parkinson's Disease.
M. P. Hart and A. Xu (2009)
J. Neurosci. 29, 7392-7394
   Full Text »    PDF »
Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c: PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE.
H. Bayir, A. A. Kapralov, J. Jiang, Z. Huang, Y. Y. Tyurina, V. A. Tyurin, Q. Zhao, N. A. Belikova, I. I. Vlasova, A. Maeda, et al. (2009)
J. Biol. Chem. 284, 15951-15969
   Abstract »    Full Text »    PDF »
The lysosome and neurodegenerative diseases.
L. Zhang, R. Sheng, and Z. Qin (2009)
Acta Biochim Biophys Sin 41, 437-445
   Abstract »    Full Text »    PDF »
{gamma}-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein.
N. Ninkina, O. Peters, S. Millership, H. Salem, H. van der Putten, and V. L. Buchman (2009)
Hum. Mol. Genet. 18, 1779-1794
   Abstract »    Full Text »    PDF »
Detecting Morphologically Distinct Oligomeric Forms of {alpha}-Synuclein.
S. Emadi, S. Kasturirangan, M. S. Wang, P. Schulz, and M. R. Sierks (2009)
J. Biol. Chem. 284, 11048-11058
   Abstract »    Full Text »    PDF »
Detection of elevated levels of soluble {alpha}-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.
K. E. Paleologou, C. L. Kragh, D. M. A. Mann, S. A. Salem, R. Al-Shami, D. Allsop, A. H. Hassan, P. H. Jensen, and O. M. A. El-Agnaf (2009)
Brain 132, 1093-1101
   Abstract »    Full Text »    PDF »
Neuropeptide Y Fragments Derived from Neprilysin Processing Are Neuroprotective in a Transgenic Model of Alzheimer's Disease.
J. B. Rose, L. Crews, E. Rockenstein, A. Adame, M. Mante, L. B. Hersh, F. H. Gage, B. Spencer, R. Potkar, R. A. Marr, et al. (2009)
J. Neurosci. 29, 1115-1125
   Abstract »    Full Text »    PDF »
A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in {alpha}-synuclein transgenic C. elegans.
T. Kuwahara, A. Koyama, S. Koyama, S. Yoshina, C.-H. Ren, T. Kato, S. Mitani, and T. Iwatsubo (2008)
Hum. Mol. Genet. 17, 2997-3009
   Abstract »    Full Text »    PDF »
Serine 129 Phosphorylation of {alpha}-Synuclein Induces Unfolded Protein Response-mediated Cell Death.
N. Sugeno, A. Takeda, T. Hasegawa, M. Kobayashi, A. Kikuchi, F. Mori, K. Wakabayashi, and Y. Itoyama (2008)
J. Biol. Chem. 283, 23179-23188
   Abstract »    Full Text »    PDF »
Neuroinflammation and Oxidation/Nitration of {alpha}-Synuclein Linked to Dopaminergic Neurodegeneration.
H.-M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, and V. M.-Y. Lee (2008)
J. Neurosci. 28, 7687-7698
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation: UNDERSTANDING THE CYTOTOXICITY OF PROTEIN PROTOFIBRILS IN NEURODEGENERATIVE DISEASE PATHOGENESIS.
N.-Y. Zhang, Z. Tang, and C.-W. Liu (2008)
J. Biol. Chem. 283, 20288-20298
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Alters Notch-1 Expression and Neurogenesis in Mouse Embryonic Stem Cells and in the Hippocampus of Transgenic Mice.
L. Crews, H. Mizuno, P. Desplats, E. Rockenstein, A. Adame, C. Patrick, B. Winner, J. Winkler, and E. Masliah (2008)
J. Neurosci. 28, 4250-4260
   Abstract »    Full Text »    PDF »
Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human {alpha}-Synuclein: A PROGRESSIVE NEURODEGENERATIVE MODEL OF DIFFUSE LEWY BODY DISEASE.
W. Zhou, J. B. Milder, and C. R. Freed (2008)
J. Biol. Chem. 283, 9863-9870
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE.
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah (2008)
J. Biol. Chem. 283, 6979-6987
   Abstract »    Full Text »    PDF »
Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease.
S. Nuber, E. Petrasch-Parwez, B. Winner, J. Winkler, S. von Horsten, T. Schmidt, J. Boy, M. Kuhn, H. P. Nguyen, P. Teismann, et al. (2008)
J. Neurosci. 28, 2471-2484
   Abstract »    Full Text »    PDF »
Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease.
K. Trinh, K. Moore, P. D. Wes, P. J. Muchowski, J. Dey, L. Andrews, and L. J. Pallanck (2008)
J. Neurosci. 28, 465-472
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein gene duplication is present in sporadic Parkinson disease.
T. -B. Ahn, S. Y. Kim, J. Y. Kim, S. -S. Park, D. S. Lee, H. J.. Min, Y. K. Kim, S. E. Kim, J. -M. Kim, H. -J. Kim, et al. (2008)
Neurology 70, 43-49
   Abstract »    Full Text »    PDF »
Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.
C. C. Stichel, X.-R. Zhu, V. Bader, B. Linnartz, S. Schmidt, and H. Lubbert (2007)
Hum. Mol. Genet. 16, 2377-2393
   Abstract »    Full Text »    PDF »
Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies.
J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto (2007)
J. Biol. Chem. 282, 28904-28914
   Abstract »    Full Text »    PDF »
Investigation of {alpha}-Synuclein Fibril Structure by Site-directed Spin Labeling.
M. Chen, M. Margittai, J. Chen, and R. Langen (2007)
J. Biol. Chem. 282, 24970-24979
   Abstract »    Full Text »    PDF »
Different Species of {alpha}-Synuclein Oligomers Induce Calcium Influx and Seeding.
K. M. Danzer, D. Haasen, A. R. Karow, S. Moussaud, M. Habeck, A. Giese, H. Kretzschmar, B. Hengerer, and M. Kostka (2007)
J. Neurosci. 27, 9220-9232
   Abstract »    Full Text »    PDF »
Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration.
W. M. Caudle, J. R. Richardson, M. Z. Wang, T. N. Taylor, T. S. Guillot, A. L. McCormack, R. E. Colebrooke, D. A. Di Monte, P. C. Emson, and G. W. Miller (2007)
J. Neurosci. 27, 8138-8148
   Abstract »    Full Text »    PDF »
Calpain-Cleavage of {alpha}-Synuclein: Connecting Proteolytic Processing to Disease-Linked Aggregation.
B. M. Dufty, L. R. Warner, S. T. Hou, S. X. Jiang, T. Gomez-Isla, K. M. Leenhouts, J. T. Oxford, M. B. Feany, E. Masliah, and T. T. Rohn (2007)
Am. J. Pathol. 170, 1725-1738
   Abstract »    Full Text »    PDF »
Translocation of {alpha}-Synuclein Expressed in Escherichia coli.
G. Ren, X. Wang, S. Hao, H. Hu, and C.-c. Wang (2007)
J. Bacteriol. 189, 2777-2786
   Abstract »    Full Text »    PDF »
Effect of 4-Hydroxy-2-nonenal Modification on {alpha}-Synuclein Aggregation.
Z. Qin, D. Hu, S. Han, S. H. Reaney, D. A. Di Monte, and A. L. Fink (2007)
J. Biol. Chem. 282, 5862-5870
   Abstract »    Full Text »    PDF »
A novel pathway for transcriptional regulation of {alpha}-synuclein.
R. L. Clough and L. Stefanis (2007)
FASEB J 21, 596-607
   Abstract »    Full Text »    PDF »
Lack of Hypoxia-Inducible Factor-1{alpha} Impairs Midbrain Neural Precursor Cells Involving Vascular Endothelial Growth Factor Signaling.
J. Milosevic, M. Maisel, F. Wegner, J. Leuchtenberger, R. H. Wenger, M. Gerlach, A. Storch, and J. Schwarz (2007)
J. Neurosci. 27, 412-421
   Abstract »    Full Text »    PDF »
{alpha}-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
E. Kontopoulos, J. D. Parvin, and M. B. Feany (2006)
Hum. Mol. Genet. 15, 3012-3023
   Abstract »    Full Text »    PDF »
Detection of novel intracellular {alpha}-synuclein oligomeric species by fluorescence lifetime imaging.
J. Klucken, T. F. Outeiro, P. Nguyen, P. J. McLean, and B. T. Hyman (2006)
FASEB J 20, 2050-2057
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models.
A. A. Cooper, A. D. Gitler, A. Cashikar, C. M. Haynes, K. J. Hill, B. Bhullar, K. Liu, K. Xu, K. E. Strathearn, F. Liu, et al. (2006)
Science 313, 324-328
   Abstract »    Full Text »    PDF »
The Two-stage Pathway of Ataxin-3 Fibrillogenesis Involves a Polyglutamine-independent Step.
A. M. Ellisdon, B. Thomas, and S. P. Bottomley (2006)
J. Biol. Chem. 281, 16888-16896
   Abstract »    Full Text »    PDF »
Etiology of Parkinson's disease.
A. H.V. Schapira (2006)
Neurology 66, S10-S23
   Abstract »    Full Text »
Enhanced expression of hypersensitive {alpha}4* nAChR in adult mice increases the loss of midbrain dopaminergic neurons.
J. Schwarz, S. C. Schwarz, O. Dorigo, A. Stutzer, F. Wegner, C. Labarca, P. Deshpande, J. S. Gil, A. J. Berk, and H. A. Lester (2006)
FASEB J 20, 935-946
   Abstract »    Full Text »    PDF »
Regional Alpha-Synuclein Aggregation, Dopaminergic Dysregulation, and the Development of Drug-Related Visual Hallucinations in Parkinson's Disease.
S. Papapetropoulos (2006)
J Neuropsychiatry Clin Neurosci 18, 149-157
   Abstract »    Full Text »    PDF »
Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human {alpha}-Synuclein(1-120): Implications for Lewy Body Disorders.
G. K. Tofaris, P. Garcia Reitbock, T. Humby, S. L. Lambourne, M. O'Connell, B. Ghetti, H. Gossage, P. C. Emson, L. S. Wilkinson, M. Goedert, et al. (2006)
J. Neurosci. 26, 3942-3950
   Abstract »    Full Text »    PDF »
6-Hydroxydopamine but Not 1-Methyl-4-phenylpyridinium Abolishes {alpha}-Synuclein Anti-apoptotic Phenotype by Inhibiting Its Proteasomal Degradation and by Promoting Its Aggregation.
C. A. da Costa, J. Dunys, F. Brau, S. Wilk, R. Cappai, and F. Checler (2006)
J. Biol. Chem. 281, 9824-9831
   Abstract »    Full Text »    PDF »
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy..
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al. (2006)
J. Neurosci. 26, 3685-3696
   Abstract »    Full Text »    PDF »
Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
N. G. Robertson, C. W.R.J. Cremers, P. L.M. Huygen, T. Ikezono, B. Krastins, H. Kremer, S. F. Kuo, M. C. Liberman, S. N. Merchant, C. E. Miller, et al. (2006)
Hum. Mol. Genet. 15, 1071-1085
   Abstract »    Full Text »    PDF »
Detection of oligomeric forms of {alpha}-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
O. M. A. El-Agnaf, S. A. Salem, K. E. Paleologou, M. D. Curran, M. J. Gibson, J. A. Court, M. G. Schlossmacher, and D. Allsop (2006)
FASEB J 20, 419-425
   Abstract »    Full Text »    PDF »
Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies.
K. Uryu, C. Richter-Landsberg, W. Welch, E. Sun, O. Goldbaum, E. H. Norris, C.-T. Pham, I. Yazawa, K. Hilburger, M. Micsenyi, et al. (2006)
Am. J. Pathol. 168, 947-961
   Abstract »    Full Text »    PDF »
Dequalinium-induced Protofibril Formation of {alpha}-Synuclein.
C.-H. Lee, H. J. Kim, J.-H. Lee, H.-J. Cho, J. Kim, K. C. Chung, S. Jung, and S. R. Paik (2006)
J. Biol. Chem. 281, 3463-3472
   Abstract »    Full Text »    PDF »
Lewy bodies.
C. W. Shults (2006)
PNAS 103, 1661-1668
   Abstract »    Full Text »    PDF »
Familial Parkinson Mutant {alpha}-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans.
T. Kuwahara, A. Koyama, K. Gengyo-Ando, M. Masuda, H. Kowa, M. Tsunoda, S. Mitani, and T. Iwatsubo (2006)
J. Biol. Chem. 281, 334-340
   Abstract »    Full Text »    PDF »
Parkinson's Disease {alpha}-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death.
L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland, N. A. Jenkins, D. L. Price, and M. K. Lee (2006)
J. Neurosci. 26, 41-50
   Abstract »    Full Text »    PDF »
Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy.
C. W. Shults, E. Rockenstein, L. Crews, A. Adame, M. Mante, G. Larrea, M. Hashimoto, D. Song, T. Iwatsubo, K. Tsuboi, et al. (2005)
J. Neurosci. 25, 10689-10699
   Abstract »    Full Text »    PDF »
Neuroanatomical Phenotyping in the Mouse: The Dopaminergic System.
C. J. Zeiss (2005)
Vet. Pathol. 42, 753-773
   Abstract »    Full Text »    PDF »
Dieldrin Induces Ubiquitin-Proteasome Dysfunction in {alpha}-Synuclein Overexpressing Dopaminergic Neuronal Cells and Enhances Susceptibility to Apoptotic Cell Death.
F. Sun, V. Anantharam, C. Latchoumycandane, A. Kanthasamy, and A. G. Kanthasamy (2005)
J. Pharmacol. Exp. Ther. 315, 69-79
   Abstract »    Full Text »    PDF »
The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways.
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean (2005)
J. Biol. Chem. 280, 23727-23734
   Abstract »    Full Text »    PDF »
Intravesicular Localization and Exocytosis of {alpha}-Synuclein and its Aggregates.
H.-J. Lee, S. Patel, and S.-J. Lee (2005)
J. Neurosci. 25, 6016-6024
   Abstract »    Full Text »    PDF »
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck (2005)
PNAS 102, 8024-8029
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Targets the Plasma Membrane via the Secretory Pathway and Induces Toxicity in Yeast.
C. Dixon, N. Mathias, R. M. Zweig, D. A. Davis, and D. S. Gross (2005)
Genetics 170, 47-59
   Abstract »    Full Text »    PDF »
Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans.
S. Cao, C. C. Gelwix, K. A. Caldwell, and G. A. Caldwell (2005)
J. Neurosci. 25, 3801-3812
   Abstract »    Full Text »    PDF »
Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.
P. K. Auluck, M. C. Meulener, and N. M. Bonini (2005)
J. Biol. Chem. 280, 2873-2878
   Abstract »    Full Text »    PDF »
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human {alpha}-Synuclein.
S. M. Fleming, J. Salcedo, P.-O. Fernagut, E. Rockenstein, E. Masliah, M. S. Levine, and M.-F. Chesselet (2004)
J. Neurosci. 24, 9434-9440
   Abstract »    Full Text »    PDF »
Stabilization of {alpha}-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation.
W. Li, C. Lesuisse, Y. Xu, J. C. Troncoso, D. L. Price, and M. K. Lee (2004)
J. Neurosci. 24, 7400-7409
   Abstract »    Full Text »    PDF »
Knockin mice with Leu9'Ser {alpha}4-nicotinic receptors: substantia nigra dopaminergic neurons are hypersensitive to agonist and lost postnatally.
S. Orb, J. Wieacker, C. Labarca, C. Fonck, H. A. Lester, and J. Schwarz (2004)
Physiol Genomics 18, 299-307
   Abstract »    Full Text »    PDF »
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
D. Yao, Z. Gu, T. Nakamura, Z.-Q. Shi, Y. Ma, B. Gaston, L. A. Palmer, E. M. Rockenstein, Z. Zhang, E. Masliah, et al. (2004)
PNAS 101, 10810-10814
   Abstract »    Full Text »    PDF »
Hsp70 Reduces {alpha}-Synuclein Aggregation and Toxicity.
J. Klucken, Y. Shin, E. Masliah, B. T. Hyman, and P. J. McLean (2004)
J. Biol. Chem. 279, 25497-25502
   Abstract »    Full Text »    PDF »
{beta}-Synuclein Regulates Akt Activity in Neuronal Cells: A POSSIBLE MECHANISM FOR NEUROPROTECTION IN PARKINSON'S DISEASE.
M. Hashimoto, P. Bar-on, G. Ho, T. Takenouchi, E. Rockenstein, L. Crews, and E. Masliah (2004)
J. Biol. Chem. 279, 23622-23629
   Abstract »    Full Text »    PDF »
Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.
Y. Pesah, T. Pham, H. Burgess, B. Middlebrooks, P. Verstreken, Y. Zhou, M. Harding, H. Bellen, and G. Mardon (2004)
Development 131, 2183-2194
   Abstract »    Full Text »    PDF »
Proteasomal Inhibition by {alpha}-Synuclein Filaments and Oligomers.
E. Lindersson, R. Beedholm, P. Hojrup, T. Moos, W. Gai, K. B. Hendil, and P. H. Jensen (2004)
J. Biol. Chem. 279, 12924-12934
   Abstract »    Full Text »    PDF »
Parkinson's disease {alpha}-synuclein mutations exhibit defective axonal transport in cultured neurons.
A. R. Saha, J. Hill, M. A. Utton, A. A. Asuni, S. Ackerley, A. J. Grierson, C. C. Miller, A. M. Davies, V. L. Buchman, B. H. Anderton, et al. (2004)
J. Cell Sci. 117, 1017-1024
   Abstract »    Full Text »    PDF »
Clearance of {alpha}-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway.
H.-J. Lee, F. Khoshaghideh, S. Patel, and S.-J. Lee (2004)
J. Neurosci. 24, 1888-1896
   Abstract »    Full Text »    PDF »
Casein Kinase II-mediated Phosphorylation Regulates {alpha}-Synuclein/Synphilin-1 Interaction and Inclusion Body Formation.
G. Lee, M. Tanaka, K. Park, S. S. Lee, Y. M. Kim, E. Junn, S.-H. Lee, and M. M. Mouradian (2004)
J. Biol. Chem. 279, 6834-6839
   Abstract »    Full Text »    PDF »
Aggresomes Formed by {alpha}-Synuclein and Synphilin-1 Are Cytoprotective.
M. Tanaka, Y. M. Kim, G. Lee, E. Junn, T. Iwatsubo, and M. M. Mouradian (2004)
J. Biol. Chem. 279, 4625-4631
   Abstract »    Full Text »    PDF »
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
R. Bandopadhyay, A. E. Kingsbury, M. R. Cookson, A. R. Reid, I. M. Evans, A. D. Hope, A. M. Pittman, T. Lashley, R. Canet-Aviles, D. W. Miller, et al. (2004)
Brain 127, 420-430
   Abstract »    Full Text »    PDF »
Rapid Anionic Micelle-mediated {alpha}-Synuclein Fibrillization in Vitro.
M. Necula, C. N. Chirita, and J. Kuret (2003)
J. Biol. Chem. 278, 46674-46680
   Abstract »    Full Text »    PDF »
Molecular Pathways of Neurodegeneration in Parkinson's Disease.
T. M. Dawson and V. L. Dawson (2003)
Science 302, 819-822
   Abstract »    Full Text »    PDF »
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons.
M. S. Goldberg, S. M. Fleming, J. J. Palacino, C. Cepeda, H. A. Lam, A. Bhatnagar, E. G. Meloni, N. Wu, L. C. Ackerson, G. J. Klapstein, et al. (2003)
J. Biol. Chem. 278, 43628-43635
   Abstract »    Full Text »    PDF »
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina (2003)
Hum. Mol. Genet. 12, 2625-2635
   Abstract »    Full Text »    PDF »
Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.
Z. Dong, B. Ferger, J.-C. Paterna, D. Vogel, S. Furler, M. Osinde, J. Feldon, and H. Bueler (2003)
PNAS 100, 12438-12443
   Abstract »    Full Text »    PDF »
Structural Organization of {alpha}-Synuclein Fibrils Studied by Site-directed Spin Labeling.
A. Der-Sarkissian, C. C. Jao, J. Chen, and R. Langen (2003)
J. Biol. Chem. 278, 37530-37535
   Abstract »    Full Text »    PDF »
LY503430, a Novel {alpha}-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease.
T. K. Murray, K. Whalley, C. S. Robinson, M. A. Ward, C. A. Hicks, D. Lodge, J. L. Vandergriff, P. Baumbarger, E. Siuda, M. Gates, et al. (2003)
J. Pharmacol. Exp. Ther. 306, 752-762
   Abstract »    Full Text »    PDF »
Parkinson's disease: piecing together a genetic jigsaw.
M. C. J. Dekker, V. Bonifati, and C. M. van Duijn (2003)
Brain 126, 1722-1733
   Abstract »    Full Text »    PDF »
Dorfin Localizes to Lewy Bodies and Ubiquitylates Synphilin-1.
T. Ito, J.-i. Niwa, N. Hishikawa, S. Ishigaki, M. Doyu, and G. Sobue (2003)
J. Biol. Chem. 278, 29106-29114
   Abstract »    Full Text »    PDF »
Certain Metals Trigger Fibrillation of Methionine-oxidized {alpha}-Synuclein.
G. Yamin, C. B. Glaser, V. N. Uversky, and A. L. Fink (2003)
J. Biol. Chem. 278, 27630-27635
   Abstract »    Full Text »    PDF »
Ubiquitination of {alpha}-Synuclein Is Not Required for Formation of Pathological Inclusions in {alpha}-Synucleinopathies.
D. M. Sampathu, B. I. Giasson, A. C. Pawlyk, J. Q. Trojanowski, and V. M.-Y. Lee (2003)
Am. J. Pathol. 163, 91-100
   Abstract »    Full Text »    PDF »
Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9.
N G Robertson, S A Hamaker, V Patriub, J C Aster, and C C Morton (2003)
J. Med. Genet. 40, 479-486
   Abstract »    Full Text »    PDF »
{alpha}-Synuclein Is Degraded by Both Autophagy and the Proteasome.
J. L. Webb, B. Ravikumar, J. Atkins, J. N. Skepper, and D. C. Rubinsztein (2003)
J. Biol. Chem. 278, 25009-25013
   Abstract »    Full Text »    PDF »
Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies.
M. Ihara, H. Tomimoto, H. Kitayama, Y. Morioka, I. Akiguchi, H. Shibasaki, M. Noda, and M. Kinoshita (2003)
J. Biol. Chem. 278, 24095-24102
   Abstract »    Full Text »    PDF »
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.
F. P. Marx, C. Holzmann, K. M. Strauss, L. Li, O. Eberhardt, E. Gerhardt, M. R. Cookson, D. Hernandez, M. J. Farrer, J. Kachergus, et al. (2003)
Hum. Mol. Genet. 12, 1223-1231
   Abstract »    Full Text »    PDF »
Parkinson's Disease-associated alpha -Synuclein Is a Calmodulin Substrate.
J. Martinez, I. Moeller, H. Erdjument-Bromage, P. Tempst, and B. Lauring (2003)
J. Biol. Chem. 278, 17379-17387
   Abstract »    Full Text »    PDF »
alpha -Synuclein Overexpression Protects against Paraquat-Induced Neurodegeneration.
A. B. Manning-Bog, A. L. McCormack, M. G. Purisai, L. M. Bolin, and D. A. Di Monte (2003)
J. Neurosci. 23, 3095-3099
   Abstract »    Full Text »    PDF »
alpha -Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats.
T. Liang, J. Spence, L. Liu, W. N. Strother, H. W. Chang, J. A. Ellison, L. Lumeng, T.-K. Li, T. Foroud, and L. G. Carr (2003)
PNAS 100, 4690-4695
   Abstract »    Full Text »    PDF »
Update on Parkinson Disease.
A. Siderowf and M. Stern (2003)
Ann Intern Med 138, 651-658
   Abstract »    Full Text »    PDF »
Cocaine Abusers Have an Overexpression of alpha -Synuclein in Dopamine Neurons.
D. C. Mash, Q. Ouyang, J. Pablo, M. Basile, S. Izenwasser, A. Lieberman, and R. J. Perrin (2003)
J. Neurosci. 23, 2564-2571
   Abstract »    Full Text »    PDF »
Aggregated and Monomeric alpha -Synuclein Bind to the S6' Proteasomal Protein and Inhibit Proteasomal Function.
H. Snyder, K. Mensah, C. Theisler, J. Lee, A. Matouschek, and B. Wolozin (2003)
J. Biol. Chem. 278, 11753-11759
   Abstract »    Full Text »    PDF »
Nigrostriatal alpha -synucleinopathy induced by viral vector-mediated overexpression of human alpha -synuclein: A new primate model of Parkinson's disease.
D. Kirik, L. E. Annett, C. Burger, N. Muzyczka, R. J. Mandel, and A. Bjorklund (2003)
PNAS 100, 2884-2889
   Abstract »    Full Text »    PDF »
Regulation of {alpha}-Synuclein Expression: Implications for Parkinson's Disease.
O. CHIBA-FALEK and R.L. NUSSBAUM (2003)
Cold Spring Harb Symp Quant Biol 68, 409-416
   Abstract »    PDF »
alpha -Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells. ABOLISHMENT BY 6-HYDROXYDOPAMINE AND IMPLICATION FOR PARKINSON'S DISEASE.
C. Alves da Costa, E. Paitel, B. Vincent, and F. Checler (2002)
J. Biol. Chem. 277, 50980-50984
   Abstract »    Full Text »    PDF »
Characterization of Cytoplasmic alpha -Synuclein Aggregates. FIBRIL FORMATION IS TIGHTLY LINKED TO THE INCLUSION-FORMING PROCESS IN CELLS.
H.-J. Lee and S.-J. Lee (2002)
J. Biol. Chem. 277, 48976-48983
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)